Equity Overview
Price & Market Data
Price: $5.50
Daily Change: $0.00 / 0.00%
Daily Range: $5.06 - $5.80
Market Cap: $534,776,320
Daily Volume: 1,938,996
Performance Metrics
1 Week: 2.04%
1 Month: -13.39%
3 Months: 10.22%
6 Months: 29.41%
1 Year: 50.68%
YTD: 10.22%
Company Details
Employees: 174
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.